Susceptibility to Fosfomycin and Nitrofurantoin of ESBL-Positive Escherichia coli and Klebsiella pneumoniae Isolated From Urine of Pediatric Patients
Ki-Sup Park, Doo Ri Kim, Jin Yang Baek, Areum Shin, Kyung-Ran Kim, Hwanhee Park, Sohee Son, Heeyeon Cho, Yae-Jean Kim · 2023
Read Susceptibility to Fosfomycin and Nitrofurantoin of ESBL-Positive Escherichia coli and Klebsiella pneumoniae Isolated From Urine of Pediatric Patients by Ki-Sup Park, Doo Ri Kim, Jin Yang Baek, Areum Shin, Kyung-Ran Kim, Hwanhee Park, Sohee Son, Heeyeon Cho, Yae-Jean Kim (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10713444.txt.
Description
Ki-Sup Park and co-authors test two oral antibiotics against resistant urinary bacteria in children in a 2023 study. Urinary infections caused by ESBL producing bacteria leave few oral treatment options. The team measured how well fosfomycin and nitrofurantoin inhibit such isolates from pediatric urine samples at a Seoul hospital.
More than one hundred isolates were collected over about a year and a half. Most were Escherichia coli, with a small share of Klebsiella pneumoniae. Most patients were infants. Dilution methods measured the minimum drug levels needed to stop growth, summarized for each drug and species to guide oral therapy choices.
Catalog record
| CREATOR | Ki-Sup Park, Doo Ri Kim, Jin Yang Baek, Areum Shin, Kyung-Ran Kim, Hwanhee Park, Sohee Son, Heeyeon Cho, Yae-Jean Kim |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 20 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |